Loading...

Naiel Nassar, MD

Title(s)Professor, Dean's Office
SchoolSchool of Medicine
Phone559-499-6500
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Naiel N. Nassar, MD, FACP
    Infectious Diseases Division Director/Program Director
    Antibiotic Stewardship Director
    Professor of Clinical Medicine, UCSF

    Naiel Nassar, M.D., specializes in infectious diseases. He is board certified in Internal Disease and Infectious Disease. His fellowship training was completed at the University of California, Davis.

    He was appointed as a faculty member in the Division of Infectious Diseases and the Medical Director of the Center for AIDS Research, Education and Services (CARES) in Sacramento.

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Saber MM, Al-Mahallawi AM, Nassar NN, Stork B, Shouman SA. Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes. BMC Cancer. 2018 Aug 15; 18(1):822. PMID: 30111296.
      View in: PubMed
    2. Azmy SM, Abd El Fattah MA, Abd El-Rahman SS, Nada SA, Abdel Salam OME, El-Yamany MF, Nassar NN. Does nicotine impact tramadol abuse? Insights from neurochemical and neurobehavioral changes in mice. Neurotoxicology. 2018 07; 67:245-258. PMID: 29906478.
      View in: PubMed
    3. Farrag SM, Hamzawy MA, El-Yamany MF, Saad MA, Nassar NN. Atorvastatin in nano-particulate formulation abates muscle and liver affliction when coalesced with coenzyme Q10 and/or vitamin E in hyperlipidemic rats. Life Sci. 2018 Jun 15; 203:129-140. PMID: 29694831.
      View in: PubMed
    4. Rabie MA, Abd El Fattah MA, Nassar NN, El-Abhar HS, Abdallah DM. Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor/PI3K/Akt/BDNF pathway and inhibition of angiotensin II type-1 receptor/NF-?B axis. Biochem Pharmacol. 2018 05; 151:126-134. PMID: 29428223.
      View in: PubMed
    5. Nafie G, Vitale G, Carbognani Ortega L, Nassar NN. Nanopyroxene Grafting with ß-Cyclodextrin Monomer for Wastewater Applications. ACS Appl Mater Interfaces. 2017 Dec 06; 9(48):42393-42407. PMID: 29112365.
      View in: PubMed
    6. Hethnawi A, Manasrah AD, Vitale G, Nassar NN. Fixed-bed column studies of total organic carbon removal from industrial wastewater by use of diatomite decorated with polyethylenimine-functionalized pyroxene nanoparticles. J Colloid Interface Sci. 2018 Mar 01; 513:28-42. PMID: 29132103.
      View in: PubMed
    7. Lee LH, Gasilina A, Roychoudhury J, Clark J, McCormack FX, Pressey J, Grimley MS, Lorsbach R, Ali S, Bailey M, Stephens P, Ross JS, Miller VA, Nassar NN, Kumar AR. Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes. JCI Insight. 2017 02 09; 2(3):e89473. PMID: 28194436.
      View in: PubMed
    8. Atef RM, Agha AM, Abdel-Rhaman AA, Nassar NN. The Ying and Yang of Adenosine A1 and A2A Receptors on ERK1/2 Activation in a Rat Model of Global Cerebral Ischemia Reperfusion Injury. Mol Neurobiol. 2018 02; 55(2):1284-1298. PMID: 28120151.
      View in: PubMed
    9. Al-Shorbagy MY, Nassar NN. Octreotide ameliorates inflammation and apoptosis in acute and kindled murine PTZ paradigms. Naunyn Schmiedebergs Arch Pharmacol. 2017 Jan; 390(1):61-68. PMID: 27695956.
      View in: PubMed
    10. Marei NN, Nassar NN, Vitale G. The effect of the nanosize on surface properties of NiO nanoparticles for the adsorption of Quinolin-65. Phys Chem Chem Phys. 2016 Mar 07; 18(9):6839-49. PMID: 26878274.
      View in: PubMed
    11. Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link KA, Chen J, Whitman SP, Bloomfield CD, Nicolet D, Assi SA, Ptasinska A, Heidenreich O, Bonifer C, Kitamura T, Nassar NN, Mulloy JC. UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO. Leukemia. 2016 Mar; 30(3):728-39. PMID: 26449661.
      View in: PubMed
    12. El-Qanni A, Nassar NN, Vitale G, Hassan A. Maghemite nanosorbcats for methylene blue adsorption and subsequent catalytic thermo-oxidative decomposition: Computational modeling and thermodynamics studies. J Colloid Interface Sci. 2016 Jan 01; 461:396-408. PMID: 26414422.
      View in: PubMed
    13. Mu A, Nassar N. A man with oral lesions, constipation and back pain. Int J STD AIDS. 2014 Jun; 25(7):526-8. PMID: 24352119.
      View in: PubMed
    14. Tawfiq RA, Nassar NN, El-Eraky WI, El-Denshary ES. Enhanced efficacy and reduced side effects of diazepam by kava combination. J Adv Res. 2014 Sep; 5(5):587-94. PMID: 25685527.
      View in: PubMed
    15. Keiser PH, Nassar N. Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational database study. Int J STD AIDS. 2008 Aug; 19(8):561-2. PMID: 18663047.
      View in: PubMed
    16. Keiser P, Nassar N. Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection. Expert Opin Pharmacother. 2007 Mar; 8(4):477-83. PMID: 17309342.
      View in: PubMed
    17. Keiser P, Nassar N, Yazdani B, Armas L, Moreno S. Comparison of efficacy of efavirenz and nevirapine: lessons learned for cohort analysis in light of the 2NN Study. HIV Clin Trials. 2003 Sep-Oct; 4(5):358-60. PMID: 14583852.
      View in: PubMed
    18. Keiser P, Nassar N, Skiest D, Andrews C, Yazdani B, White A, Hetherington S. Comparison of symptoms of influenza A with abacavir-associated hypersensitivity reaction. Int J STD AIDS. 2003 Jul; 14(7):478-81. PMID: 12869229.
      View in: PubMed
    19. Keiser P, Nassar N, White C, Koen G, Moreno S. Comparison of nevirapine- and efavirenz-containing antiretroviral regimens in antiretroviral-naïve patients: a cohort study. HIV Clin Trials. 2002 Jul-Aug; 3(4):296-303. PMID: 12187503.
      View in: PubMed
    20. Keiser P, Nassar N. Trizivir. Expert Opin Pharmacother. 2002 May; 3(5):619-24. PMID: 11996639.
      View in: PubMed
    21. Coordinated community programs for HIV prevention among intravenous-drug users--California, Massachusetts. MMWR Morb Mortal Wkly Rep. 1989 Jun 02; 38(21):369-74. PMID: 2497335.
      View in: PubMed
    Naiel's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (206) concept(s)
    _
    Similar People
    People who share similar concepts with this person.
    See all (60) people
    _
    Same Department
    Search Department
    ↑